Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
[Phe3]OT | 3106 | None | 0 | Human | Binding | pKi | None | - | 8.80 | 50 | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/7774575 | |
[Phe3]OT | 3106 | None | 0 | Human | Binding | pKi | None | - | 8.80 | 50 | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/8955347 | |
[Thr4,Gly7]OT | 3815 | None | 0 | Human | Binding | pKi | = | - | 8.30 | 44 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/7475979 | |
[Thr4,Gly7]OT | 3815 | None | 0 | Human | Binding | pKi | = | - | 8.30 | 44 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/8955347 | |
[Thr4,Gly7]OT | 3815 | None | 0 | Human | Binding | pKi | = | - | 8.30 | 44 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/2827511 | |
[Thr4,Gly7]OT | 3815 | None | 0 | Human | Binding | pKi | = | - | 8.30 | 44 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/23723434 | |
arginine vasotocin | 466 | None | 0 | Human | Binding | pKi | = | - | 9.40 | 7 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/7774575 | |
arginine vasotocin | 466 | None | 0 | Human | Binding | pKi | = | - | 9.40 | 7 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/8955347 | |
atosiban | 518 | None | 30 | Human | Binding | pKi | None | - | 6.80 | -46 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10519430 | |
atosiban | 518 | None | 30 | Human | Binding | pKi | None | - | 6.80 | -46 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12660315 | |
atosiban | 518 | None | 30 | Human | Binding | pKi | None | - | 6.80 | -46 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/14722330 | |
atosiban | 518 | None | 30 | Human | Binding | pKi | None | - | 6.80 | -46 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/15880385 | |
atosiban | 518 | None | 30 | Human | Binding | pKi | None | - | 6.80 | -46 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/7475979 | |
Atosiban | 218972 | 3H-Oxytocin | 0 | Human | Binding | pKi | = | 27.00 | 7.57 | -4 | 5 | - | PDSP KiDatabase | 993.4 | 18 | 11 | 15 | -3.04 | CCOc1ccc(CC2NC(=O)CCSSCC(C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC2=O)cc1 | - | |
Atosiban | 218972 | None | 0 | Human | Binding | pKi | = | 7.96 | 8.10 | -4 | 5 | Binding affinity to human oxytocin receptor | Drug Central | 993.4 | 18 | 11 | 15 | -3.04 | CCOc1ccc(CC2NC(=O)CCSSCC(C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC2=O)cc1 | - | |
atosiban | 518 | None | 30 | Human | Binding | Ki | = | 397.00 | 6.40 | -46 | 5 | Binding affinity to oxytocin receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmcl.2008.11.064 | |
atosiban | 518 | None | 30 | Human | Binding | Ki | = | 32.00 | 7.50 | -46 | 5 | Binding affinity to recombinant oxytocin receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmcl.2007.11.008 | |
atosiban | 518 | None | 30 | Human | Binding | Ki | = | 11.00 | 7.96 | -46 | 5 | Binding affinity to human oxytocin receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmcl.2007.11.008 | |
atosiban | 518 | None | 30 | Human | Binding | Ki | = | 39.81 | 7.40 | -46 | 5 | Displacement of [3H]oxytocin from human OTR | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm060073e | |
atosiban | 518 | None | 30 | Human | Binding | Ki | = | 27.00 | 7.57 | -46 | 5 | Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm050645f |
Showing 1 to 20 of 1,472 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
[Mpa1,D-Tyr(Et)2,D-Tic7,Aib9]OT | 2608 | None | 0 | Human | Functional | pIC50 | None | - | 7.10 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/17316912 | |
[Mpa1,D-Tyr(Et)2,D-Tic7,D-Tic9]OT | 2610 | None | 0 | Human | Functional | pIC50 | None | - | 7.60 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/17316912 | |
[Mpa1,D-Tyr(Et)2,D-Tic7]OT | 2609 | None | 0 | Human | Functional | pIC50 | None | - | 7.30 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/17316912 | |
atosiban | 518 | None | 30 | Human | Functional | IC50 | = | 372.00 | 6.43 | -12 | 5 | Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.ejmech.2017.05.013 | |
atosiban | 518 | None | 30 | Human | Functional | IC50 | = | 59.00 | 7.23 | -12 | 5 | Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm050645f | |
atosiban | 518 | None | 30 | Rat | Functional | Kd | = | 5.13 | 8.29 | 1 | 5 | Antagonist activity in rat uterus by uterotonic assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.ejmech.2006.12.016 | |
atosiban | 518 | None | 30 | Rat | Functional | IC50 | = | 12.00 | 7.92 | 1 | 5 | Antagonism of OT-induced response at OT receptor in rat uterine strips | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmcl.2005.10.107 | |
carbetocin | 797 | None | 33 | Human | Functional | EC50 | = | 10.00 | 8.00 | 1 | 5 | Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay | ChEMBL | - | - | - | - | - | CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O | https://dx.doi.org/10.1021/acs.jmedchem.8b00697 | |
carbetocin | 797 | None | 33 | Human | Functional | EC50 | = | 41.00 | 7.39 | 1 | 5 | Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay | ChEMBL | - | - | - | - | - | CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O | https://dx.doi.org/10.1021/acs.jmedchem.8b00697 | |
carbetocin | 797 | None | 33 | Human | Functional | pEC50 | = | - | 8.00 | 1 | 5 | Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay. | Guide to Pharmacology | - | - | - | - | - | CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O | https://pubmed.ncbi.nlm.nih.gov/30199637 | |
carbetocin | 797 | None | 33 | Mouse | Functional | pEC50 | = | - | 7.21 | -10 | 5 | Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay. | Guide to Pharmacology | - | - | - | - | - | CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O | https://pubmed.ncbi.nlm.nih.gov/30199637 | |
carbetocin | 797 | None | 33 | Mouse | Functional | EC50 | = | 62.00 | 7.21 | -10 | 5 | Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay | ChEMBL | - | - | - | - | - | CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O | https://dx.doi.org/10.1021/acs.jmedchem.8b00697 | |
CHEMBL1077300 | 5605 | None | 0 | Human | Functional | Ki | = | 13.90 | 7.86 | - | 1 | Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay | ChEMBL | 359.2 | 5 | 0 | 4 | 3.25 | CCN(C(=O)N1CC(Oc2cccc(F)c2C)C1)c1ccc(OC)nc1 | https://dx.doi.org/10.1016/j.bmcl.2010.01.143 | |
CHEMBL1088765 | 7694 | None | 0 | Human | Functional | Ki | = | 85.00 | 7.07 | - | 1 | Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay | ChEMBL | 336.2 | 5 | 0 | 5 | 3.25 | CCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 | https://dx.doi.org/10.1016/j.bmcl.2010.02.018 | |
CHEMBL1088766 | 7695 | None | 0 | Human | Functional | Ki | = | 98.00 | 7.01 | - | 1 | Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay | ChEMBL | 366.2 | 7 | 0 | 6 | 2.88 | COCCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 | https://dx.doi.org/10.1016/j.bmcl.2010.02.018 | |
CHEMBL1088767 | 7696 | None | 0 | Human | Functional | Ki | = | 91.00 | 7.04 | - | 1 | Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay | ChEMBL | 366.2 | 6 | 0 | 6 | 3.26 | CCN(C(=O)c1cnn(-c2ccc(OC)cc2)c1C)c1ccc(OC)nc1 | https://dx.doi.org/10.1016/j.bmcl.2010.02.018 | |
CHEMBL1089025 | 7741 | None | 0 | Human | Functional | Ki | = | 129.00 | 6.89 | - | 2 | Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay | ChEMBL | 348.2 | 5 | 0 | 5 | 3.52 | CCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 | https://dx.doi.org/10.1016/j.bmcl.2010.02.018 | |
CHEMBL1089026 | 7742 | None | 0 | Human | Functional | Ki | = | 150.00 | 6.82 | - | 1 | Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay | ChEMBL | 362.2 | 5 | 0 | 5 | 3.91 | COc1ccc(N(C(=O)c2cnc(-c3ccccc3C)cn2)C(C)C)cn1 | https://dx.doi.org/10.1016/j.bmcl.2010.02.018 | |
CHEMBL1089272 | 7773 | None | 0 | Human | Functional | Ki | = | 48.00 | 7.32 | - | 1 | Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay | ChEMBL | 336.1 | 6 | 0 | 4 | 3.67 | CCN(C(=O)COc1ccc2ccccc2c1)c1ccc(OC)nc1 | https://dx.doi.org/10.1016/j.bmcl.2010.02.018 | |
CHEMBL1089391 | 7788 | None | 0 | Human | Functional | Ki | = | 19.70 | 7.71 | - | 1 | Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay | ChEMBL | 369.2 | 5 | 0 | 7 | 2.69 | COc1ccc(-n2c(C)nnc2N2CC(Oc3cccc(F)c3C)C2)cn1 | https://dx.doi.org/10.1016/j.bmcl.2010.01.143 |
Showing 1 to 20 of 463 entries